StonvexLoading…
StonvexCore line items from AMPL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $343.21M | $299.27M | $276.28M | $238.07M |
Operating Income | $-85.33M | $-92.53M | $-89.09M | $-92.58M |
Net Income | $-88.54M | $-94.32M | $-90.36M | $-93.38M |
EPS (Diluted) | $-0.67 | $-0.76 | $-0.77 | $-0.84 |
Total Assets | $420.68M | $445.91M | $433.68M | $413.75M |
Total Liabilities | $175.34M | $149.35M | $138.93M | $118.79M |
Cash & Equivalents | $81.12M | $171.68M | $248.49M | $218.49M |
Free Cash Flow OCF − CapEx | $28.20M | $16.78M | $24.35M | $-9.02M |
Shares Outstanding | 131.98M | 123.90M | 116.94M | 111.44M |